Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/61998
Type
ArticleCopyright
Restricted access
Embargo date
2030-12-31
Collections
- INI - Artigos de Periódicos [3646]
Metadata
Show full item record
EVALUATION OF GLOMERULAR FILTRATION RATE TRENDS IN PEOPLE LIVING WITH HIV CORRECTED BY THE BASELINE GLOMERULAR FILTRATION RATE
People living with HIV
Antiretroviral therapy
Kidney dysfunction
Linear mixed-effects model
Renal health
Author
Affilliation
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil / State University of Rio de Janeiro. Pedro Ernesto University Hospital. Faculty of Medical Sciences. Clínical and Academic Unit of Nephrology. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. Pedro Ernesto University Hospital. Faculty of Medical Sciences. Clínical and Academic Unit of Nephrology. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
State University of Rio de Janeiro. Pedro Ernesto University Hospital. Faculty of Medical Sciences. Clínical and Academic Unit of Nephrology. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Oswaldo Cruz Foundation. Evandro Chagas National Institute of Infectology. SDT/AIDS Clinical Research Laboratory. Rio de Janeiro, RJ, Brazil.
Abstract
Background: Chronic kidney disease, for which estimated glomerular filtration rate (eGFR) trajectories are early markers, is frequent in people living with HIV. Setting: Identify eGFR trajectory patterns according to kidney function and assess associated factors over a 13-year follow-up period. Methods: We evaluated longitudinal changes and its associated factors in eGFR of 3366 participants according to kidney function with a 2-level, linear, mixed model. Results: Participants with initial kidney dysfunction experienced a slight eGFR increase, whereas others showed a slight decrease. A weak relationship was observed between baseline eGFR and its variation over time. Baseline eGFR was affected by age, CD4 + count, viral load, hypertension, hyperlipidemia, AIDS-defining illness and tenofovir (TDF) with integrase inhibitor (INSTI) or efavirenz. Significant factors for eGFR change included the following: in kidney dysfunction, CD4 + cell count of >350 cells per cubic millimeter and undetectable viral load increased eGFR, whereas TDF + protease inhibitor decreased eGFR; in mildly decreased kidney function, CD4 + cell count of >350 cells per cubic millimeter, AIDS-defining illness, and TDF + efavirenz increased eGFR, whereas age, hypertension, hyperlipidemia, and TDF + INSTI decreased eGFR; in normal kidney function, age, CD4 + cell count of > 350 cells per cubic millimeter, undetectable viral load, hypertension, hyperlipidemia, and TDF + INSTI decreased eGFR, whereas TDF + efavirenz increased eGFR (all P value for interaction < 0.05). Conclusion: Our findings suggest that eGFR trajectories varied widely between individuals in people living with HIV. In the lower eGFR group, virus-related factors were more relevant, whereas traditional risk factors for renal dysfunction were more prominent in the highest eGFR group.
Keywords
Estimated glomerular filtration ratePeople living with HIV
Antiretroviral therapy
Kidney dysfunction
Linear mixed-effects model
Renal health
Share